Jeff is an Associate at OMERS Life Sciences in Toronto and is responsible for conducting scientific due diligence and financial analysis on potential investment opportunities, assisting in deal execution, and assisting in the management of existing investments across the Life Sciences portfolio. He joined the team in May 2022.

Prior to joining OMERS, Jeff spent three years conducting fundamental research within the biotechnology sector as an equity research analyst at Rosalind Capital, a long-short life sciences specialist hedge fund in Toronto. Jeff previously worked at ApoPharma Inc., the innovative drug division of Apotex, where he was responsible for a broad range of clinical research drug development activities.

Jeff holds a Master of Science degree in Physiology and Pharmacology and a Bachelor of Medical Sciences from Western University. He has passed all three CFA examinations.